Literature DB >> 9091146

Mesothelial versus endothelial cell seeding: evaluation of cell adherence to a fibroblastic matrix using 111In oxine.

J M Bellón1, N García-Honduvilla, C Escudero, M J Gimeno, L Contreras, J de Haro, J Buján.   

Abstract

OBJECTIVES: The aim of this study was to compare the behaviour of mesothelial cells (MC) to that of endothelial cells (EC) when seeded onto a PTFE, prosthesis coated with a fibroblastic matrix. DESIGN,
MATERIAL AND METHODS: Three study groups were examined: a control group (Control) of PTFE prostheses with a fibroblast matrix (n = 8); Group EC, PTFE prostheses seeded with EC on a fibroblastic matrix (n = 8); and Group MC, PTFE, prostheses seeded with MC on a fibroblastic matrix (n = 8). All cell types were labelled with 111In (100 microCi/ml) 24 h after seeding, when the cells had formed a monolayer on the prosthetic surface. Radioactive levels were measured at 2, 4, 6, and 24 h.
RESULTS: Both EC and MC showed optimal adherence. The MC had a better radioactive uptake and retention than the EC. The number of EC and MC cells that remained adherent to the matrix was large enough to ensure complete covering of the prosthetic surface.
CONCLUSION: The use of MC is therefore feasible as an optimal alternative for achieving a natural covering on vascular prostheses prepared with a fibroblastic matrix.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9091146     DOI: 10.1016/s1078-5884(97)80010-x

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  2 in total

1.  In vitro mesothelialization of prosthetic materials designed for the repair of abdominal wall defects.

Authors:  J M Bellón; N García-Honduvilla; R López; C Corrales; F Jurado; J Buján
Journal:  J Mater Sci Mater Med       Date:  2003-04       Impact factor: 3.896

Review 2.  Cellular engineering of vascular bypass grafts: role of chemical coatings for enhancing endothelial cell attachment.

Authors:  H J Salacinski; A Tiwari; G Hamilton; A M Seifalian
Journal:  Med Biol Eng Comput       Date:  2001-11       Impact factor: 3.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.